[Federal Register Volume 61, Number 206 (Wednesday, October 23, 1996)]
[Notices]
[Page 55074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-27081]
[[Page 55073]]
_______________________________________________________________________
Part II
Department of Health and Human Services
_______________________________________________________________________
Office of the Secretary
_______________________________________________________________________
Announcement of the Establishment of the Advisory Committee on Blood
Safety and Availability and Request for Nominations for Members of the
Committee; Notice
Federal Register / Vol. 61, No. 206 / Wednesday, October 23, 1996 /
Notices
[[Page 55074]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Announcement of the Establishment of the Advisory Committee on
Blood Safety and Availability and Request for Nominations for Members
of the Committee
AGENCY: Office of the Secretary, DHHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of the Secretary announces the establishment by the
Secretary, October 9, 1996, of the Advisory Committee on Blood Safety
and Availability (ACBSA). In addition, the Office of the Secretary
requests nominations for representatives to serve on the ACBSA in
accordance with its charter. Initial appointments of representatives
shall be made for staggered terms of two to four years.
DATES: All nominations must be received at the address below by no
later than 4:00 PM EDT on November 13, 1996.
ADDRESSES: All nomination packages shall be submitted to Eric Goosby,
M.D., Office of Public Health and Science, Department of Health and
Human Services, Room 736 E, 200 Independence Ave. S.W., Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Linda A. Smallwood, Ph.D., Center for
Biologics Evaluation and Research, HFM-350, Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 20852. Tel (301)
827-3514.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act, Public Law 92-493 as amended (5 U.S.C. App.2), and section 222 of
the Public Health Service Act as amended (42 U.S.C. 217a), the Office
of the Secretary announces establishment by the Secretary of the
following Federal advisory committee:
Purpose
The Committee will provide advice to the Secretary and the
Assistant Secretary for Health on a range of issues which include: (1)
the implications for blood safety and availability of various economic
factors affecting product cost and supply; (2) definition of public
health parameters around safety and availability of the blood supply;
and (3) broad public health, ethical, and legal issues related to
safety of the blood supply.
Authority for the committee shall expire on October 9, 1998, unless
the Secretary of Health and Human Services, with the concurrence of the
Committee Management Secretariat, General Services Administration,
determines that the continuance is in the public interest.
Nominations
Persons nominated for membership should be from among authorities
knowledgeable in blood banking, transfusion medicine, bioethics and
related disciplines. Members shall be selected from among State and
local organizations, the blood and blood products industry including
manufacturers and distributors, advocacy groups, consumer advocates,
provider organizations, academic researchers, ethicists, private
physicians, behavioral scientists, legal organizations, and from
communities of persons who are frequent recipients of blood and blood
products.
Members shall be invited to serve for overlapping terms: terms of
more than two years are contingent upon the renewal of the committee by
appropriate action prior to its expiration. Of the first members
appointed, excluding the non-voting ex officio members, six shall serve
for a term of two years, six for a term of three years, and six for a
term of four years, as designated at the time of appointment.
Information Required
Each nomination shall consist of a package that at minimum
includes:
A. A letter of nomination that clearly states the name and
affiliation of the nominee, the nominator's basis for the nomination,
the category for which the person is nominated, and a statement that
the nominee is willing to serve as a member of the Committee;
B. The name, return address, and daytime telephone number at which
the nominator may be contacted, and the address and telephone number
for the individual being nominated. Organizational nominators must
identify a principal contact person in addition to contact information;
C. A copy of the nominee's curriculum vitae.
All nomination information for a nominee must be provided in a
complete single package. Incomplete nominations cannot be considered.
Nomination materials must bear original signatures and facsimile
transmissions or copies are not acceptable.
Philip R. Lee,
Assistant Secretary for Health.
[FR Doc. 96-27081 Filed 10-22-96; 8:45 am]
BILLING CODE 4160-17-M
